Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Oncology
Description:
Welcome to our podcast, where today we discuss lung cancer—one of the most common and serious cancers worldwide. The primary risk factor for lung cancer is smoking, but exposure to second-hand smoke, radon gas, asbestos, and air pollution can also increase your risk. Family history and certain genetic factors may play a role as well. The good news is that many lung cancer cases can be prevented. Quitting smoking, avoiding exposure to harmful substances, and choosing a healthy lifestyle with regular exercise all help lower your risk. Early detection is vital, so speak to your healthcare provider if you have concerns. Remember, knowledge and proactive choices are your best defence.
See More Webinars @ Hidoc Webinars
1.
A small rise in cancer was observed following the 1986 Chernobyl accident.
2.
Smoldering Myeloma: The Treatment Issue Is Getting Trickier
3.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
4.
Exercise can counter detrimental effects of cancer treatment, review suggests
5.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
1.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
2.
Managing Hematoma: A Guide to Prevention and Treatment
3.
Transformative Methods in Oncology and Quality Improvement
4.
Florinef: Understanding Its Uses and Side Effects
5.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
Should We Use DARA Up Front As First-Line Therapy in MM?
3.
Lung Cancer: Risk Factors and Prevention
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge